TPR:NYSETapestry, Inc. Analysis
Data as of 2026-05-05 - not real-time
$141.45
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
TPR is trading at $141.45, roughly 14% below its DCF‑derived fair value of $152.12, suggesting upside potential. The stock sits comfortably above its 20‑day SMA (147.79) and 50‑day SMA (146.80), yet below both, indicating a short‑term pull‑back within a longer bullish framework. Support at $139.16 is holding, while resistance near $158.56 remains distant. Technical momentum is mixed: RSI at 43 points to neutral territory and the MACD histogram is bearish, flagging near‑term downside pressure. Volatility is elevated at ~36% over the past 30 days and a beta of 1.5 signals higher sensitivity to market swings. Recent headlines highlight a Q3 earnings call, a global expansion push, and a 14% revenue rise to $2.5 B driven by a 25% surge in Coach sales, all of which reinforce the growth narrative.
Fundamentally, Tapestry delivers a 14% revenue growth rate, 76% gross margin, and a strong ROE of 55%, underscoring operating excellence. Forward earnings estimates of $7.23 per share compress the forward P/E to 19.6, a marked improvement over the trailing 54.6. The dividend yield of 1.14% with a 58% payout ratio appears sustainable given robust cash flow. Analyst consensus remains a “Buy” with a mean target of $162, implying an additional 14% upside. While the current valuation is still high on a price‑to‑book basis, the DCF gap and growth trajectory tilt the balance toward being undervalued. Overall, the stock presents a compelling blend of growth, cash generation, and modest dividend income for investors willing to tolerate sector volatility.
Fundamentally, Tapestry delivers a 14% revenue growth rate, 76% gross margin, and a strong ROE of 55%, underscoring operating excellence. Forward earnings estimates of $7.23 per share compress the forward P/E to 19.6, a marked improvement over the trailing 54.6. The dividend yield of 1.14% with a 58% payout ratio appears sustainable given robust cash flow. Analyst consensus remains a “Buy” with a mean target of $162, implying an additional 14% upside. While the current valuation is still high on a price‑to‑book basis, the DCF gap and growth trajectory tilt the balance toward being undervalued. Overall, the stock presents a compelling blend of growth, cash generation, and modest dividend income for investors willing to tolerate sector volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support at $139.16
- Bearish MACD histogram
- Upcoming Q3 earnings call
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside of ~14%
- 14% revenue growth and strong margins
- Sustainable dividend with solid cash flow
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- High ROE and operating cash generation
- Global expansion and digital innovation
- Long‑term brand positioning in luxury segment
Key Metrics & Analysis
Financial Health
Revenue Growth14.00%
Profit Margin6.95%
P/E Ratio54.6
ROE55.34%
ROA15.02%
Debt/Equity715.48
P/B Ratio52.0
Op. Cash Flow$1.8B
Free Cash Flow$1.4B
Technical Analysis
TrendBullish
RSI43.4
Support$139.16
Resistance$158.56
MA 20$147.79
MA 50$146.80
MA 200$124.67
MACDBearish
VolumeDecreasing
Fear & Greed Index90.61
Valuation
Fair Value$152.12
Target Price$162.16
Upside/Downside14.64%
GradeUndervalued
TypeGrowth
Dividend Yield1.14%
Risk Assessment
Beta1.54
Volatility35.99%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.